JSCRX
Price
$17.15
Change
+$0.26 (+1.54%)
Updated
Apr 24 closing price
Net Assets
2.76B
VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
Ad is loading...

JSCRX vs VEXRX

Header iconJSCRX vs VEXRX Comparison
Open Charts JSCRX vs VEXRXBanner chart's image
PGIM Jennison Small Company R
Price$17.15
Change+$0.26 (+1.54%)
VolumeN/A
Net Assets2.76B
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
JSCRX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSCRX vs. VEXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCRX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. JSCRX (2.76B). VEXRX pays higher dividends than JSCRX: VEXRX (0.56) vs JSCRX (0.42). JSCRX was incepted earlier than VEXRX: JSCRX (21 years) vs VEXRX (23 years). JSCRX (1.56) is less costly to investors than VEXRX (0.34). JSCRX is a more actively managed with annual turnover of: 66.00 vs. VEXRX (35.00). JSCRX has a lower initial minimum investment than VEXRX: JSCRX (0) vs VEXRX (50000). JSCRX annual gain was more profitable for investors over the last year : -4.98 vs. VEXRX (-11.24). JSCRX (18.33) and VEXRX (17.63) have equivalent 5 years return.
JSCRXVEXRXJSCRX / VEXRX
Total Expense Ratio1.310.34385%
Annual Report Gross Expense Ratio1.560.34459%
Fund Existence21 years23 years-
Gain YTD-13.162-13.37498%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.76B19.8B14%
Annual Yield % from dividends0.420.5674%
Returns for 1 year-4.98-11.2444%
Returns for 3 years-7.39-8.9682%
Returns for 5 years18.3317.63104%
Returns for 10 years-34.430.85-4,057%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI80.891.79
+2.26%
SPDR® S&P Biotech ETF
FEP42.410.74
+1.78%
First Trust Europe AlphaDEX® ETF
SBIO28.510.49
+1.75%
ALPS Medical Breakthroughs ETF
BCDF28.980.44
+1.54%
Horizon Kinetics Blockchain Dev ETF
CHI9.920.14
+1.43%
Calamos Convertible Opportunities and Income Fund